
    
      The investigators know from the studies, that were already published, that for HER2 positive
      early breast cancer patients in adjuvant treatment concomitant radiotherapy and trastuzumab
      is safe during the treatment. But there is no study with long term results of cardial
      function, especially combination of Left ventricular ejection fraction (LVEF) and NT-proBNP.
    
  